These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11850784)

  • 21. Telomere shortening and chromosomal instability abrogates proliferation of adult but not embryonic neural stem cells.
    Ferrón S; Mira H; Franco S; Cano-Jaimez M; Bellmunt E; Ramírez C; Fariñas I; Blasco MA
    Development; 2004 Aug; 131(16):4059-70. PubMed ID: 15269166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telomere lengthening in telomerase-negative cells: the ends are coming together.
    Scheel C; Poremba C
    Virchows Arch; 2002 Jun; 440(6):573-82. PubMed ID: 12070595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [1997, a good year for telomerase?].
    Gilson E
    Bull Cancer; 1998 Feb; 85(2):119-23. PubMed ID: 9752327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mathematical model of cellular apoptosis and senescence through the dynamics of telomere loss.
    Arkus N
    J Theor Biol; 2005 Jul; 235(1):13-32. PubMed ID: 15833310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomerase-immortalized human fibroblasts retain UV-induced mutagenesis and p53-mediated DNA damage responses.
    Porter PC; Clark DR; McDaniel LD; McGregor WG; States JC
    DNA Repair (Amst); 2006 Jan; 5(1):61-70. PubMed ID: 16140041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomeres and telomerase in adrenocortical tissue maintenance, carcinogenesis, and aging.
    Else T
    J Mol Endocrinol; 2009 Oct; 43(4):131-41. PubMed ID: 19411304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative stress causes telomere damage in Fanconi anaemia cells - a possible predisposition for malignant transformation.
    Uziel O; Reshef H; Ravid A; Fabian I; Halperin D; Ram R; Bakhanashvili M; Nordenberg J; Lahav M
    Br J Haematol; 2008 Jul; 142(1):82-93. PubMed ID: 18477050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes.
    Swiggers SJ; Kuijpers MA; de Cort MJ; Beverloo HB; Zijlmans JM
    Genes Chromosomes Cancer; 2006 Mar; 45(3):247-56. PubMed ID: 16281260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRF2 inhibition promotes anchorage-independent growth of telomerase-positive human fibroblasts.
    Brunori M; Mathieu N; Ricoul M; Bauwens S; Koering CE; Roborel de Climens A; Belleville A; Wang Q; Puisieux I; Décimo D; Puisieux A; Sabatier L; Gilson E
    Oncogene; 2006 Feb; 25(7):990-7. PubMed ID: 16205637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retroviral-mediated expression of telomerase in normal human cells provides a selective growth advantage.
    Forsythe HL; Elmore LW; Jensen KO; Landon MR; Holt SE
    Int J Oncol; 2002 Jun; 20(6):1137-43. PubMed ID: 12011990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA.
    Li S; Rosenberg JE; Donjacour AA; Botchkina IL; Hom YK; Cunha GR; Blackburn EH
    Cancer Res; 2004 Jul; 64(14):4833-40. PubMed ID: 15256453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomere uncapping, chromosomes, and carcinomas.
    Batista LF; Artandi SE
    Cancer Cell; 2009 Jun; 15(6):455-7. PubMed ID: 19477422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomere erosion triggers growth arrest but not cell death in human cancer cells retaining wild-type p53: implications for antitelomerase therapy.
    Preto A; Singhrao SK; Haughton MF; Kipling D; Wynford-Thomas D; Jones CJ
    Oncogene; 2004 May; 23(23):4136-45. PubMed ID: 15064743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres.
    Roake CM; Artandi SE
    Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28289249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomere maintenance in tumour cells.
    Bacchetti S
    Cancer Surv; 1996; 28():197-216. PubMed ID: 8977036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Many ways to telomere dysfunction: in vivo studies using mouse models.
    Goytisolo FA; Blasco MA
    Oncogene; 2002 Jan; 21(4):584-91. PubMed ID: 11850783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mice without telomerase: what can they teach us about human cancer?
    Artandi SE; DePinho RA
    Nat Med; 2000 Aug; 6(8):852-5. PubMed ID: 10932211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis.
    Chin L; Artandi SE; Shen Q; Tam A; Lee SL; Gottlieb GJ; Greider CW; DePinho RA
    Cell; 1999 May; 97(4):527-38. PubMed ID: 10338216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomerase: not just black and white, but shades of gray.
    Liu JP
    Mol Cell Biol Res Commun; 2000 Mar; 3(3):129-35. PubMed ID: 10860859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rebuilding the road to cancer.
    Weitzman JB; Yaniv M
    Nature; 1999 Jul; 400(6743):401-2. PubMed ID: 10440363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.